U.S. Diabetic Retinopathy Market Will Grow Rapidly In Coming Years
U.S. Diabetic Retinopathy Market Summary The U.S. diabetic retinopathy market size was estimated at USD 3.02 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2030. This anticipated growth is driven by multiple key factors, including the expanding geriatric population, a surge in diabetes cases due to sedentary lifestyles and poor dietary habits, the increasing prevalence of obesity, and the high cost of treating the condition. In addition, the market is being positively influenced by the introduction and rising adoption of advanced technologies such as artificial intelligence (AI), data analytics, and smart diabetes management devices, all of which are contributing to better diagnosis and treatment outcomes. Diabetic retinopathy is a serious complication that arises from both type I and type II diabetes. It impacts the tiny blood vessels located in the retina, and if not managed properly, can progressively deteriora...